CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-18 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,000 | 16,017 | ||
| 2024-11-07 | Levy Richard S Director | Option exercise | +1,303 | 14,200 | ||
| 2024-11-07 | Levy Richard S Director | Grant or award · Restricted Share Units | +1,303 | 1,303 | ||
| 2024-11-07 | Levy Richard S Director | Option exercise · Restricted Share Units | −1,303 | 0 | ||
| 2024-11-06 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +89,561 | $1.59 | $142K | 169,112 |
| 2024-11-06 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −89,561 | $23.00 | $2.1M | 79,551 |
| 2024-11-06 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −89,561 | 10,025 | ||
| 2024-10-15 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,000 | $1.59 | $16K | 126,975 |
| 2024-10-15 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −17,000 | $26.87 | $457K | 109,975 |
| 2024-10-15 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,000 | 26,017 | ||
| 2024-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +175 | 26,610 | ||
| 2024-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −82 | $24.48 | $2K | 26,528 |
| 2024-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −175 | 175 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,730 | 128,802 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,730 | 2,730,419 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +28,384 | 28,384 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +28,384 | 28,384 | ||
| 2024-09-23 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,000 | $1.59 | $16K | 134,475 |
| 2024-09-23 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −17,500 | $24.99 | $437K | 116,975 |
| 2024-09-23 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,000 | 36,017 |
Page 45 of 74 · 1,467 trades